Innovation

Peng Li, MD, PhD, ARUP medical director, seeks to increase awareness to the newly discovered VEXAS syndrome with a recently published blog and paper.

Visit booth #2455 at the American Society of Hematopathology (ASH) Annual Meeting and Exposition to speak with ARUP hematopathologists and learn about the latest in laboratory testing for hematologic diseases.

Presentations by ARUP medical directors and scientists at AMP 2024 included timely topics in molecular pathology such as automated DNA extraction. Melanie Mallory, MS, pictured above, a lead bioinformatics scientist at ARUP, presented a poster related to the prediction of viral loads for cytomegalovirus.

Michelle Tarver, MD, PhD, director of the FDA’s Center for Devices and Radiological Health (CDRH), and Jeff Shuren, MD, JD, CDRH director emeritus, appeared virtually at the Utah Life Sciences Summit.

Carl Wittwer, MD, PhD, with the LightCycler^® he invented in the 1990s.

A new test that ARUP offers for preeclampsia risk measures the ratio between two angiogenic factors (sFlt-1 and PlGF) that are produced by the placenta and are involved in the pathophysiology of preeclampsia.

The Tasso+ self-collection device can be shipped directly to patients, facilitating remote collection of whole blood samples and eliminating the need for lab visits.

Presenters include Kimberly Hanson, MD, MHS; David Ng, MD; Patricia Slev, PhD, D(ABCC); Tammy Smith, MD, PhD; and Nicholas Spies, MD.

The research grant is named in honor of retired ARUP CEO Sherrie Perkins, MD, PhD, whose leadership laid the groundwork for ARUP’s increased focus on innovation.

Representative Blake Moore (R-Utah, District 1) speaks during a House Committee on Ways and Means hearing held at ARUP Laboratories. Pictured from left to right are Celeste Maloy (R-Utah, District 2), Burgess Owens (R-Utah, District 4), Moore, Jason Smith (R-Missouri, District 8), and Brad Wenstrup, MD (R-Ohio, District 2).

Rep. Blake Moore (R-UT) and other members of the Ways and Means Committee’s Health Subcommittee will participate in a field hearing on July 12 at ARUP Laboratories.

Andy Theurer, ARUP CEO, speaks to a crowd gathered to celebrate ARUP’s 40th anniversary. Others on stage include, from left to right, Tracy I. George, MD, ARUP chief scientific officer and president of the Innovation Business Unit, Julio C. Delgado, MD, MS, ARUP executive vice president and vice chair and chief of Clinical Pathology at the University of Utah, and Carl R. Kjeldsberg, MD, an ARUP founder and former CEO.